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Epithelial sodium channels (ENaC) are generally responsible for the passive movement 
of sodium ions through the apical cell membrane of salt absorbing epithelia. Canonical 
ENaC is composed of three homologous subunits, most commonly being a 
combination of alpha, beta, and gamma subunits (αβɣ-ENaC). However, in humans, 
ENaC has also been found to exist as a combination of delta, beta, and gamma subunits 
(δβɣ-ENaC). 
ENaC subunits were also detected in the endothelium of arteries where they are 
exposed to shear stress from the blood flow. αβɣ-ENaC is known to be activated by 
shear stress and inhibit vascular relaxation potentially exacerbating the effects of 
hypertension. A potential new treatment option for hypertension is targeting arterial 
ENaC through carbon monoxide (CO). CO has been tested as an emerging potential 
treatment for cardiovascular disease and hypertension. Studies have shown conflicting 
effects of CO on αβɣ-ENaC activity. Currently the effect of CO on δβɣ-ENaC have been 
characterized, and how the effect of shear stress compared between αβγ-ENaC and 
δβγ-ENaC. 
Therefore, I aimed to use Two Electrode Voltage Clamping (TEVC) and Xenopus laevis 
oocytes expressing αβɣ-ENaC or δβɣ-ENaC, to examine how both types of ENaCs 
respond to shear stress and CO. Our data shows δβɣ-ENaC responds to shear stress in 
a dose dependent manner that is less sensitive compared to the response seen in αβɣ-
ENaC. This suggests δβɣ-ENaC may potentially play a role in hypertension, but further 
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experimentation is needed to confirm if it influences vascular relaxation like αβɣ-ENaC. 
Furthermore, no significant response was seen by both ENaCs towards carbon 
monoxide, but a strong biphasic trend was noted in δβɣ-ENaC that was not seen in 
αβɣ-ENaC. This suggests that carbon monoxide has potential in modulating αβɣ-ENaC 
activity that is based on concentration. Further experimentation to confirm this trend 
may place carbon monoxide as a potential therapeutic in the treatment of hypertension 
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Hypertension is a medical condition characterized by chronically elevated blood 
pressures, potentially causing damage to the arterial walls. This disease affects over a 
billion people worldwide and is a primary risk factor for cardiovascular diseases, 
including stroke, and heart attacks. As of currently, there are multiple drugs to treat the 
condition including ACE-inhibitors, diuretics and beta blockers. But some patients who 
take a multiple medications to combat the disease are still unable to lower the blood 
pressure to normal ranges. This raises the need for a better understanding of the 
disease in order to develop more effective treatments.  
ENaC, or otherwise known as epithelial sodium channels are responsible for the passive 
movement of sodium ions through the apical cell membrane of salt absorbing epithelia. 
ENaC is composed of multiple subunits, and in humans namely the subunits mainly 
form αβγ-ENaC, or δβγ-ENaC. αβγ-ENaC has been shown to be responsive to shear 
stress, a phenomenon that is increased during hypertension. And increased αβγ-ENaC 
activity has been shown to inhibit vascular relaxation, potentially exacerbating the 
effects of hypertension. δβγ-ENaC has been found to be expressed in the endothelium 
of arteries including the aorta. But how the effects of shear stress on δβγ-ENaC 
compares to αβγ-ENaC is currently unclear. Therefore, a better understanding on how 
δβγ-ENaCs respond to elevated shear stress such as during hypertension, may 
potentially allow us to better understand the disease. 
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On the other hand, carbon monoxide is under research in the treatment of 
cardiovascular diseases. And furthermore, carbon monoxide has also been shown to 
have an inhibitory effect on αβγ-ENaC. However, how carbon monoxide affects δβγ-
ENaC is currently unknown, but a better understanding here may place carbon 
monoxide as a potential therapeutic in the treatment of hypertension.  
Therefore, we will aim to compare how these two ENaCs respond to shear stress, as 





Epithelial sodium channels are members of the ENaC/Degenerin Superfamily of 
proteins (Canessa et al., 1994). ENaC are predominantly found on the apical membrane 
of the epithelial lining of the kidney (Hager et al., 2001) and the lungs (Enuka et al., 
2012). ENaC facilitates the passive movement of sodium ions (Na+) into the tissue 
(Hanukoglu & Hanukoglu, 2016). This results in a net movement of sodium ions into 
the tissue, increasing the solute concentration within the tissue. This creates an osmotic 
gradient, driving water uptake via osmosis (Hanukoglu & Hanukoglu, 2016). Therefore, 
ENaC plays a major role water homeostasis and blood pressure regulation (Pratt, 2005; 
Sharma et al., 2017). 
1.2.1 Structure 
Structurally, ENaC is a heterotrimer, and is composed of three homologous subunits of 
either alpha (α), beta (β), gamma (γ), or delta (δ) subunits (Canessa et al., 1994). And it 
was only until recently that ENaC was confirmed to be a trimer (Noreng et al., 2018), as 
ENaC’s stoichiometry was heavily debated prior (Shobair et al., 2016).  
In humans, ENaC is most commonly found to be composed of α, β, and γ subunits. 
These will be hence be referred to as αβγ channels (Fig. 1A). Because they are the 
predominant combination found in epithelia, most studies have been focused around 
this configuration of subunits. There is another combination of subunits of significant 
interest and is composed of δ, β, and γ subunits and will hence referred to as δβγ-ENaC 
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(Fig. 1B). These have been less well studied as they are only found in humans and not 














Figure 1: General overview of ENaC structure. 
 A. General structure of αβγ channels, composed of three subunits forming a pore like 
structure. B. General structure of δβγ channels also forming a pore like structure. C. 
Basic ENaC subunit structure including two transmembrane domains and a long 
extracellular loop. The C and N-termini are found in the cell interior. 
 
 
As mentioned earlier, ENaC proteins are members of the ENaC/degenerin superfamily 


















features including a large extracellular loop found between two transmembrane 
domains, with short intracellular C- and N- termini (Canessa et al., 1994; Kashlan & 
Kleyman, 2011) (Fig. 1C). In humans, the structure of the extracellular loops is similar 
between each ENaC subunit (Kashlan & Kleyman, 2011). But, the structures of the C- 
and N- termini of ENaC has yet to be determined. 
The extracellular domain in ENaC exhibit characteristic regions including β-ball, finger, 
knuckle, palm and thumb domains that are connected to their transmembrane 
domains via a wrist region (Noreng et al., 2018) (Fig. 2). A further region of interest is 
the GRIP (Gating Relief of Inhibition by Proteolysis) domain, which has been elucidated 
to play a role in the gating of ENaC (Noreng et al., 2018).  
Figure 2: The extracellular loop of ENaC.  
A visual representation of the extracellular loop, showing the Ball, Finger, GRIP, Knuckle, 






ENaC in general, provides a passage for the passive movement of sodium ions into the 
cell, down its electrochemical gradient, and is the rate limiting step for sodium uptake. 
The electrochemical gradient is driven by a basolateral sodium potassium ATPase 
pump (Na+/K+-ATPase), pumping out three sodium ions in exchange for 2 potassium 
ions. The potassium ions are recycled out of the cell passively, via a basolateral 
potassium channel (Garty & Palmer, 1997). This causes a net movement of sodium ions 
into the tissue, increasing the tissues solute concentration, creating an osmotic 
gradient (Palmer & Andersen, 2008) (Fig. 3). Therefore, water is driven into the tissue 
down its osmotic gradient, resulting in net water absorption (Palmer & Andersen, 2008). 
It has been shown that the α subunit alone can facilitate the movement of sodium ions 
through the cell membrane (Canessa et al., 1994). However, only upon coexpression 
with both beta and gamma subunits does sodium transport increase 100-fold 
compared to the α subunit alone (Canessa et al., 1994). A similar phenomenon is seen 
with the δ subunit, where the δ subunit alone can facilitate sodium movement, however, 
coexpression with beta and gamma subunits  increases sodium transport 2-fold 
(Haerteis et al., 2009). Furthermore, δβγ-ENaC produces amiloride sensitive currents 
that are 11 times that of αβγ-ENaC (Haerteis et al., 2009). 
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Figure 3: General overview of ENaC function. 
Where blue dots represent sodium ions, yellow dots potassium ions and the grey dots 
as water. Basolateral sodium potassium pump provides electrochemical gradient for 
sodium resorption through ENaC. Net flow of sodium causes solute concentration to 
increase within the tissue, resulting in water uptake through both the transcellular 
pathway and paracellular pathway. 
 
 
ENaC is also amiloride sensitive. Upon amiloride administration, ENaC mediated 
sodium transport is reduced by blockage of the ENaC pore, restricting ion access 
through the channel (Canessa et al., 1993). This reduces the open probability of ENaC 
which will be discussed further in the regulation section. The mechanism behind this 
effect was shown to be a direct blockage of the ENaC pore by amiloride, preventing 
Na+ passage (Palmer, 1984). This amiloride sensitive characteristic of ENaC has been 
vital in the research and understanding of ENaC activity. Its perfusion during electrical 
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recordings allows the determination of amiloride sensitive current, the current that is 
attributed to ENaC. 
1.2.3 Regulation 
ENaC is a constitutively active channel, meaning it is always active when inserted into 
the cell membrane (Garty & Palmer, 1997). But ENaC mediated sodium transport (I) 
may be modulated in two ways (Fig. 4). Either by altering the open probability of the 
channel or changing the surface expression (N) of the channel. Both ways can result in 
changes to sodium transport, however, modulating the open probability generally 
leads to an acute effect when compared to modulating the surface expression. This is 
because it requires time to synthesize more ENaC. 
Figure 4: ENaC-mediated sodium transport regulation. 
General graphical representation of ENaC activity (I) regulation via either altering the 





1.2.3.1 Open Probability 
The open probability (Po) of ENaC is the probability that the channel is open in any 
point in time. By altering this open probability, the net movement of sodium ions can 
be modulated, and hence the net water movement may change as well. Open 
probability has been shown to be modulated via many factors, including extracellular 
sodium concentrations (Fuchs et al., 1977), pH (Chalfant et al., 1999), and proteases 
(Kleyman et al., 2009). Importantly, the open probability of ENaC has been shown to 
be modulated by shear stress (Althaus et al., 2007) and will be discussed in detail in the 
shear stress section. 
1.2.3.2 Surface expression 
The surface expression of ENaC, or the number of ENaC found on the surface of the 
cell membrane may also be altered to modulate ENaC mediated sodium transport 
activity.  This requires a careful balance between ENaC internalization (Ubiquitination) 
from the membrane and insertion (Aldosterone) into the membrane.  
ENaC contains a proline rich sequence called the PY motif found in the cytoplasmic C-
terminal region of ENaC subunits (Schild et al., 1996; Staub et al., 1996). Here, Nedd4-
2, a ubiquitin-protein ligase binds and adds a ubiquitin tag to it (ubiquitination), 
marking ENaC for internalization and breakdown (Harvey et al., 1999; Kamynina et al., 
2001; Malik et al., 2005). This results in a reduced surface expression of ENaC. 
Aldosterone, a hormone, promotes the increased abundance ENaC in the cell surface 
when blood volume is sensed to be low. Aldosterone is released by the adrenal gland 
to increase blood volume, pressure and to maintain extracellular sodium 
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concentrations (Bollag, 2011). Aldosterone binds to mineralocorticoid receptors, 
activating serum glucocorticoid kinase 1 (SGK). SGK1 in turn phosphorylates ubiquitin-
protein ligase Nedd4-2. Preventing Nedd4-2 from acting on ENaC for internalization 
(Debonneville et al., 2001). This reduced internalization results in increased surface 





Hypertension is a chronic medical condition where blood pressure in the arteries is 
persistently elevated above normal ranges (NHLBI, 2018). Having a high blood pressure 
itself does not result in immediate consequences for the patient. However, chronic 
hypertension is a major risk factor in cardiovascular diseases including stroke and heart 
failure (NHBLI, 2018). 
Blood pressure is affected by total cardiac output, and total peripheral resistance. 
Importantly in relation to ENaC, blood pressure may be modulated through total blood 
volume (Kidneys) (Evans & Bie, 2015), affecting the cardiac output and arterial stiffness 
(Endothelium) which affects the total peripheral resistance (Perez et al., 2009). 
1.3.1 Kidneys 
As mentioned previously, ENaC mediated sodium transport drives water uptake 
(Palmer & Andersen, 2008). This novel function of ENaC mediated sodium transport 
puts ENaC in an important position in water homeostasis, which influences blood 
volume. This is particularly true in the kidneys where ENaC is found in abundance along 
the epithelium of the distal nephron to aid in water resorption from the glomerular 
filtrate (Rossier et al., 2013). And therefore, a disturbance in its activity may lead 
disrupted water homeostasis, and hence altering blood volume (Rossier, 2014). 
A well-known disease that results in hypertension from ENaC malfunction in the 
kidneys is Liddle’s syndrome (Schild, 1996). Liddle’s syndrome is a rare genetic disorder 
where the PY-motif of ENaC has obtained gain-of-function mutations (Schild et al., 
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1995; Schild et al., 1996). This prevents the binding of Nedd4-2 to ENaC to undergo 
ubiquitination, resulting in reduced internalization of ENaC on the cell surface, meaning 
there is a greater abundance of ENaC expressed (Schild et al., 1995; Schild et al., 1996). 
As stated earlier, ENaC-mediated sodium transport can be modulated via surface 
expression. And therefore, an increased surface abundance of ENaC results in increased 
sodium resorption, increased water resorption and increased blood volume. This 
ultimately raises the blood pressure of the patient resulting in severe hypertension 
(Snyder et al., 1995; Firsov et al., 1996). 
As of currently treatments for this disease includes a reduced sodium diet and 
amiloride administration. These treatments combined reduces ENaC-dependent 
sodium absorption in the kidneys and hence reduced water resorption, bringing blood 
volume and pressure back towards normal. 
1.3.2 Vascular Endothelium 
Contrary to its name, ENaC has been shown to be found in non-epithelial tissues as 
well. ENaC has been previously been shown to be present in microvascular 
endothelium (Chen et al., 2004; Wang et al., 2009), and unpublished data from the 
Fronius lab has also found evidence of its presence in human arteries, likely in the 
endothelium.  
ENaC in vascular endothelium has been shown to play a role in affecting vascular 
relaxation via endothelial Nitric Oxide Synthase (eNOS) (Perez et al., 2009). eNOS in 
arteries is an enzyme that catalyzes the synthesis of nitric oxide (NO), a small gaseous 
molecule that has a role in many biological processes (Sessa, 2004). Importantly, NO 
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produced by eNOS in the vascular endothelium is an important regulator of vascular 
relaxation. This is because NO inhibits voltage gated Ca2+ channels in vascular smooth 
muscle, reducing the cytosolic Ca2+ concentration (Bolotina et al., 1994). This reduction 
in Ca2+ ions prevents contraction of the vascular smooth muscle, resulting in 
vasorelaxation (Horowitz et al., 1996). This reduces the total peripheral resistance, 
hence reducing blood pressure. 
However, ENaC mediated sodium transport has been shown to be an inhibitor of eNOS 
activity (Perez et al., 2009). This causes reduced NO synthesis and hence reduced 
vascular smooth muscle relaxation, resulting increased total peripheral resistance and 
blood pressure. This suggests ENaC influences the development of hypertension in 




1.4 Shear Stress 
Shear stress is a physical phenomenon where a passing flow of fluid such as blood in 
the arteries exerts frictional forces against the surrounding tissue, such as the 
endothelium in arteries (Fig. 5). This causes a mechanical deformation of the tissue and 
may lead to activation of mechanosensitive components found on the membrane of 
the tissue.  
Figure 5: Visual representation of the mechanism of shear stress 
Visual representation of how shear stress causes deformation of the 
epithelial/endothelial lining. The passing flow of fluid causes physical deformation and 
stretch of the tissue lining. 
 
 
ENaC has been shown previously to be mechanosensitive to shear stress (Althaus et al., 
2007; Fronius et al., 2010). And studies done using Rat and Xenopus αβγ-ENaC have 
indicated that αβγ-ENaC responds to shear stress in a dose dependent manner 
(Carattino et al., 2004; Althaus et al., 2007). The studies showed that an increase in shear 
stress resulted in upregulation of αβγ-ENaC open probability, which increases ENaC-











The exact mechanism behind this phenomenon is not well understood and two models 
were proposed. The bilayer model, where channels are gated by membrane 
deformation as a result of shear stress administration (Hamill & Martinac, 2001). And 
the tethered model, where mechanical forces are transduced to the channel through a 
tether attached to either the intracellular and/or extracellular matrix (Hamill & Martinac, 
2001). Unfortunately, neither model has convincing evidence to support them. 
Carattino et al. (2007) found that altering properties of the lipid membrane resulted in 
no change to the ENaC response to shear stress, disproving the bilayer model. And the 
tethered model was disproven in a study where activation of ENaC via shear stress was 
not affected when the actin cytoskeleton was disrupted (Karpushev et al., 2010).  
As of currently, it is proposed that the extracellular loops are involved in this mechanical 
activation (Althaus et al., 2007). A study found that upon proteolytic cleavage of the 
extracellular loops, different response to shear stress were seen in different orthologs 
(Althaus et al., 2007). This is further supported by another study where mutations at 
selected sites within the loop altered the magnitude of ENaC activation in response to 
shear stress (Shi et al., 2011). Further studies are needed to confirm the exact 
mechanism behind the shear stress induced ENaC effect. 
However, regardless of its mechanism, in hypertension where blood flow is increased, 
ENaC found along the endothelium lining will be exposed to increased levels of shear 
stress, resulting in its upregulation of ENaC mediated sodium transport. And as stated 
previously, this in arteries will result in inhibited vascular relaxation (Perez et al., 2009), 
potentially exacerbating the effects of hypertension.   
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1.5 Carbon Monoxide 
Carbon monoxide is commonly known as a colourless, odourless gas that upon 
inhalation in high concentrations results in suffocation. Carbon monoxide exerts its 
toxic effects by strongly binding to the iron atoms of heme. This binding prevents 
oxygen uptake, and hence impedes oxygen transport. Prolonged exposure to this toxic 
gas results in tissue hypoxia and ultimately, death (Piantadosi, 2002; Gorman et al., 
2003). Because of these deadly characteristics of the diatomic molecule, research into 
its presence in the human physiology has been delayed until recently, where the gas 
has been found to function as a gasotransmitter in the human body (Verma et al., 1993).  
Figure 6: Endogenous synthesis of carbon monoxide from heme in the human 
body catalyzed by hemoxygenase. 
The breakdown of heme is catalysed by Hemoxygenase where it forms iron, biliverdin 
and carbon monoxide. 
 
 
Carbon monoxide is endogenously synthesized in the human body via the oxidation of 
heme, where biliverdin and iron are also produced as byproducts (Maines, 1997) (Fig. 
6). This reaction is catalysed by the enzyme hemoxygenase (HO), and two isoforms are 
found in the human body, an inducible HO-1 isoform and a constitutive HO-2 isoform 
(Maines, 1997). Both isoforms are expressed in many tissues around the human body, 









(Ewing et al., 1994). Of course, carbon monoxide may also be exogenously 
administrated through direct gas inhalation, or in a more clinically relevant form that 
allows precise dosing, carbon monoxide releasing molecules (CORMS). However, due 
to the metal carbonyl structure of CORMs, CORMs typically present as a long term 
health risk (Foresti et al., 2008; Garcia-Gallego & Bernardes, 2014). Therefore, there is 
currently research in organic CORMs that are non-metallic, which is less toxic than 
traditional CORMs (Abeyrathna et al., 2017).  
These carbon monoxides releasing molecules are important, as carbon monoxide is 
currently under development as a drug for cardiovascular diseases because carbon 
monoxide has been shown to influence smooth muscle proliferation (Morita et al., 1997; 
Song et al., 2002) and platelet aggregation (Brune & Ullrich, 1987; Chlopicki et al., 2012). 
But perhaps most importantly in relation to this project, carbon monoxide has been 
shown to influence ENaC activity. It has been shown that upon application of carbon 
monoxide in the form of CORM-3. ENaC-mediated Na transport is inhibited in a dose 
response fashion. And this effect likely affects the open probability of ENaC as 
treatment with cell trafficking inhibitors resulted in no change of the ENaC response to 
carbon monoxide (Althaus et al., 2009).  
However, it has also been shown that carbon monoxide is able to increase ENaC-
mediated Na transport, also via increasing open probability (Wang et al., 2009). These 
conflicting results may suggest a tissue specific mechanism of carbon monoxide as the 
inhibitory response was seen in alveolar type 2 cells (Althaus et al., 2009), whereas the 
activation response was seen in cells of the kidney cortical collecting duct (Wang et al., 
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2009). As there are currently only these two studies on the effect of carbon monoxide 
on ENaC, the exact effect of carbon monoxide is uncertain. However, grasping a better 
understanding of the effect, may potentially pose carbon monoxide as a potential 
therapeutic in the treatment of hypertension. This is because as stated earlier, ENaC is 
upregulated by shear stress (Althaus et al., 2007), and upregulated ENaC activity leads 
to inhibition of vascular relaxation (Perez et al., 2009), which potentially exacerbates 
the effect of hypertension. Therefore, the use of carbon monoxide as a potential 
inhibitor of ENaC may prevent the inhibition of vascular relaxation, alleviating some 
effects of hypertension. 
1.6 δβγ-Channels 
Up to now, all data presented in terms of shear stress and carbon monoxide etc. has 
only been tested in αβγ-ENaC. Therefore, little is known about δβγ-ENaC including its 
response to carbon monoxide. The lack of studies likely arises due to it being not 
expressed in mice (Giraldez et al., 2012), and has only recently been discovered. 
As the name implies, unlike αβγ-ENaC, δβγ-ENaC contain a δ subunit instead of an α 
subunit. And as stated earlier, the δ subunit alone is also capable of sodium transport, 
and sodium transport activity is greatly enhanced by forming an amiloride sensitive 
heterotrimer with β and γ subunits (Haerteis et al., 2009). But as the δ subunit on shares 
34 % gene identity with the α subunit (Hanukoglu & Hanukoglu, 2016), differences in 
function are to be expected. 
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Functionally, δβγ-ENaC has been shown experimentally to have an 11-fold higher open 
probability and hence greater sodium conductance when compared to αβγ-ENaC 
(Haerteis et al., 2009). Also, δβγ-ENaC have a greater affinity for sodium ions over 
lithium ions, unlike αβγ-ENaC (Canessa et al., 1994).  
δβγ-ENaC are also expressed in different tissues when compared to αβγ-ENaC which 
are highly expressed in salt-absorbing epithelia. Instead, δβγ-ENaC are highly 
expressed in the parts of the brain, heart, liver, pancreas, skeletal muscle, and to a 
smaller degree, regions of the kidney (Waldmann et al., 1995; Yamamura et al., 2004). 
But most importantly, unpublished data from the Fronius lab has found δβγ channels 
presence in the endothelium of human arteries, therefore it may potentially also play a 
role in ENaC-mediated inhibition of vascular relaxation. This is of particular relevance 
as it has been shown δβγ-ENaC also responds so shear stress (Abi-Antoun et al., 2011). 
But whether this response is also dose-dependent and how it compares to the 
response seen in αβγ-ENaC is still unknown. 
Therefore, a better understanding of how δβγ channels responds to shear stress, may 
provide a better understanding of hypertension. And furthermore, a better 
understanding of how δβγ channels respond to carbon monoxide may pose carbon 
monoxide as a potential therapeutic in the treatment of hypertension. 
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1.7 Aims and Hypothesis 
1.7.1 Shear Stress 
Based on current knowledge of ENaC, it is well known that both αβγ-ENaC and δβγ-
ENaC is responsive to shear stress, but how the response compares between the two 
types of ENaC is unknown. Given that δβγ-ENaC has been shown to have a higher open 
probability than αβγ-ENaC. I hypothesize that a dose-dependent response to shear 
stress will be seen in both αβγ-ENaC and δβγ-ENaC, and the response is greater in δβγ-
ENaC.  
Aim: Compare how the shear stress response is different between human αβγ-ENaC 
and δβγ-ENaC. 
1.7.2 Carbon Monoxide 
There is currently sparse literature on the effect of carbon monoxide on ENaC, with 
only two articles describing conflicting effects in αβγ-ENaC. However, it is clear that 
carbon monoxide does influence ENaC activity in some way. Therefore, I hypothesize 
carbon monoxide causes an inhibitory response in both αβγ-ENaC and δβγ-ENaC, with 
a greater response in δβγ-ENaC. 
Aim: Identify the effects of carbon monoxide on both αβγ-ENaC and δβγ-ENaC, and 










Oocytes from Xenopus laevis were used to express the ENaC channels of interest. And 
by applying increasing levels of shear stress and oCOM-21b, the resulting effects on 
ENaC mediated sodium transport were assessed using Two Electrode Voltage 
Clamping (TEVC). The composition of all solutions used in this project can be found in 
table 1 below: 











NaCl mM 90 90 90 10 90 
KCl mM 1 1 1 1 1 
CaCl2 mM 2 2 - 2 2 
HEPES mM 5 5 5 5 5 
MgCl2 mM - - 1 - - 
Na+-Pyruvate mM 2.5 - - 2.5 - 
NMDG mM - - - 80 - 
EGTA mM - - 1 - - 
Amiloride mM - - - - 100 
Penicillin mM 0.06 - - 0.06 - 
Streptomycin mM 0.02 - - 0.02 - 
Tetracycline µg/mL 50 - - 50 - 
Legend Table 1: µg/mL = micrograms per microliter; Ca2+ = Calcium ion; CaCl2 = 
Calcium Chloride; CulORi = Culture Oocyte Ringers; EGTA = ethylene glycol-bis(β-
aminoethyl ether)-N,N,N’,N’-tetraacetic acid; HEPES = 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic Acid; KCl = Potassium Chloride; MgCl2 = Magnesium 
Chloride; mM = millimolar; Na+-Pyruvate = Sodium Pyruvate; NMDG = N-Methyl-D-
glucamine ; Ori = Oocyte Ringers.  
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2.2 Xenopus laevis oocytes: 
We used oocytes from the South African clawed frog, Xenopus laevis as the cell model 
due to their large single cell size, allowing ease of manipulation in TEVC. We 
heterologously expressed αβγ channels and δβγ channels in these oocytes using cRNA 
encoding either channel.  It is important to note the import and containment of the 
frogs were approved by the Environmental Protection Authority (EPA approval number: 
NOC100153). And the harvesting of oocytes approved by the University of Otago’s 
Animal Ethics Committee (AEC approval number: 83-16). 
2.2.1 Oocyte Harvest: 
Firstly, the oocytes were harvested from the frogs in order to be used in 
experimentation. Under normal circumstances, the oocytes would be harvested via 
surgery, with time allotted between surgeries for the recovery of the animals, and up 
to 3 surgeries per frog. However, as all frogs have already undergone all 3 permitted 
surgeries, the oocytes used in this experiment were obtained after euthanasia of the 
animal. All procedures were recorded accordingly in the animal register located next 
to each tank and clean gloves were worn throughout the handling of frogs and oocytes. 
To perform euthanasia, the frog was placed under anaesthesia via submersion in water 
containing Tricaine Methane Sulfonate (MS-222, Aldrich, Cat.No. E10521-50G) (1.3 g/L, 
pH 7.4) for 10-15 minutes. Successful anaesthesia was then confirmed via the pedal 
and righting reflexes. The pedal reflex was confirmed by gently pulling the leg of the 
frog away from its body, if retraction was observed, anaesthesia has not taken place. 
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The righting reflex was confirmed by flipping the frog over on to its dorsal side, if the 
frog attempts to correct itself back into the upright position, anaesthesia has not taken 
place. An anaesthetized frog suitable for oocyte collection will not exhibit the above 
reflexes. 
After successful anaesthesia was confirmed, the frog was transferred onto a custom-
built guillotine, where a stainless-steel rod punctures through the animal’s neck, 
resulting severance of the spinal cord, hence death. Death is further confirmed via 
insertion of a thin metal probe into the spinal column to further destroy the spinal 
column. 
Following euthanasia, using sharp scissors, a small vertical incision was made in 
between the midline and the lateral aspect of the abdomen just above the groin. 
Scissors were then used to cut through the muscular layer to where the ovarian lobes 
are located. The ovarian lobes were then externalized with forceps and cut off and 
placed into culture oocyte ringer’s solution (CulORi) for storage. The animal was then 
placed in a sealed bag and disposed of appropriately in a designated freezer.  It is 





2.2.2 Oocyte isolation and cultivation 
Oocytes were then separated from the ovarian lobes into single oocytes via both 
physical and enzymatical processes. The extracted ovarian lobes were first placed into 
a clean 100 mm x 20 mm petri dish (Corning, New York, USA) containing CulORi, and 
each lobe physically torn apart using two thin-headed forceps. Thin-headed forceps 
were used in this procedure to minimise damage to the oocytes. 
Following this, we performed enzymatic defolliculation of the oocytes. The oocytes 
were transferred into a new clean 100 mm x 20 mm petri dish (Corning, New York, USA) 
containing CulORi with collagenase (Nordmark, Cat. No. S1746502) added (1.5 mg/mL). 
The plates were then sealed using parafilm and placed on a platform rocker (Select 
Bioproducts, NJ, USA) for an incubation period of 90 minutes at 80 RPM. Oocytes were 
then rinsed three times in CulORi before being transferred into a 50 mL conical bottom 
tube (Grenier Bio-One, Frickenhausen, Germany) with Ca2+ free oocyte solution (Ca2+ 
free ori) for 15 minute incubation whilst being rotated using a rotator (Thermo 
Scientific, PA, USA). 
After this treatment, the now singular oocytes are transferred into another 100 mm x 
20 mm petri dish (Corning, New York, USA) containing CulORi for sorting. Fully-grown, 
undamaged and healthy-looking stage V-VI oocytes (Fig. 7) were selected and stored 
individually in a 96-well plate, each well containing 200 µL N-Methyl-D-Glucamin 
CulORi (NMDG) for cRNA injection. Or, sorted oocytes were placed into a separate 
clean petri dish containing CulORi for storage. Both were incubated in a low 
temperature incubator (Jeio Tech, Seoul, South Korea) at 17°C for storage. 
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Figure 7: Visualization of stages in Xenopus laevis oocyte development.   
The development of Xenopus laevis oocytes ranges from youngest (Stage I) to most 
mature (Stage VI) before maturing into fertilization competent eggs. Only oocytes at 




2.2.3 cRNA Injection 
cRNA encoding human α, δ, β, and γ subunits was provided by the Fronius Lab. These 
were stored in –80 ᵒC freezers in both single subunit and mixed aliquots. The mixed 
aliquots of αβγ-ENaC and δβγ-ENaC had equimolar concentrations of each subunit i.e. 
α:β:γ and δ:β:γ were 1:1:1.  
After defrosting the cRNA, aliquots of cRNA encoding αβγ-ENaC and δβγ-ENaC were 
placed into separate .5 μL Non-stick, RNAse free microcentrifuge tubes (Invitrogen, 
California, USA) for use in injection. The injection process involved an automated high 
throughput system, Roboinject (Multichannel systems, Reutlingen, Germany). This 
system allows precise injection of each oocyte in the 96 well plate with the 
programmed amount of solution (Fig. 8). Here, oocytes were injected with 20 nL of 
11.25 ng/μL cRNA encoding either αβγ-ENaC or δβγ-ENaC. Water controls were also 
injected with 20 nL of RNAse free water to control for the injection process. In summary, 
three groups of oocytes result from this injection process, αβγ-ENaC injected oocytes, 
δβγ-ENaC injected oocytes, and water-injected oocytes as shown in Figure 8 below. 
Following injection, the injected oocytes were incubated in the low temperature 
incubator at 17 ᵒC over 24-72 hours. 
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Figure 8: Visualization of cRNA injection procedure.  
The oocytes in a 96 well plate was injected using Roboinject system. 2.25 ng of cRNA 
encoding either αβγ channels or δβγ channels were injected. 20 nL of RNAse free water 









24 - 72 hours 
at 17 °C 
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2.3 Two Electrode Voltage-Clamp (TEVC) 
Two Electrode Voltage-clamping (TEVC) was used to assess the effects of shear stress 
and carbon monoxide on ENaC expressing oocytes. TEVC is a well-established 
technique in which the cell is artificially held at a set membrane potential, and changes 
in membrane current can be recorded. This is particularly useful in measuring ion 
channel activity due to the charged nature of ions. 
TEVC involves a total of 4 electrodes, two bath electrodes, a voltage electrode to 
measure membrane potential, and finally a current electrode which passes electrical 
current into the cell to control the membrane potential.  
2.3.1 Roboocyte2 
Roboocyte2 (Multichannel systems, Reutlingen, Germany) is an automated high 
throughput system used to perform TEVC on Xenopus laevis oocytes.  This system is 
composed of the Roboocyte2 (Multichannel systems, Reutlingen, Germany), the robot 
itself to perform TEVC as well as a fluid perfusion system to control perfusion of fluids, 
Roboflow (Multichannel systems, Reutlingen, Germany). A computer was used to run 
Roboocyte2s proprietary software for recording of the electrical activity, as well as the 
control and scripting of the robot.  
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In the Roboocyte2 system (Fig. 10), the 4 electrodes required for TEVC, along with the 
perfusion tubes are incorporated into a single measuring head that is proprietary to 
the system (Fig. 9). The proprietary measuring microelectrodes (chlorided silver wires) 
were placed in the glass capillaries of the supplied measuring head, backfilled with 3 
M KCl. The bath electrodes were also proprietary chlorided silver wires and submerged 
directly into the bath solution. 
Figure 9: Schematic of Roocyte2 proprietary measuring head assembly. 
Roboocyte2 uses a proprietary measuring head, incorporating measuring electrodes, 




Perfusion Tubes Bath Electrodes 
Measuring Electrodes Full Assembly Full Assembly (Side View) 
32 
 
The system also incorporates a peristaltic pump to drive the perfusion of the recording 
well, as well as a separate peristaltic pump to remove excess solution from the 
recording chamber. The speed of each pump can be modulated individually. 
Figure 10: Schematic of Roboocyte2 TEVC System.  
The Roobocyte2 system is linked to Roboflow for solution perfusion in each well. 
Roboflow allows attachment of up to 12 solution reservoirs and may be individually 
controlled via electromagnetic valves. The perfusion tubes from each reservoir is linked 
to a peristaltic pump that drives the perfusion of the recording chamber.  A separate 
peristaltic pump removes excess solution from each well into a waste beaker. 
Roboocyte2 holds the 96 well plate on a plate carrier that moves on the platform via a 
cushion of air. The plate carrier moves the plate so the well of interest is directly under 
the measuring head. The positioning of the measuring head and plate carriers are 
calibrated initially using a specialised microscope and calibration tool. 
 
Using the supplied software, scripts can be written to automate each perfusion 
protocol as well as the recording process. 
2.3.3.1 Roboocyte2 Scripting 
As Roboocyte2 is an automated system, scripting was needed to ensure the correct 
events occurred at the right time. The syntax used in the Roboocyte2 system is a 
Javascript based language and allows fine control over the recording procedure of each 
experiment. In general, the script first defines variables and checks the parameters 
















The oocyte loop is a section of code that is responsible for the recording of each oocyte. 
It begins by compensating the electrode DC voltage offsets at each electrode, before 
testing those in the bath solution. Afterwards, the measuring electrodes impale the 
oocyte, and measures the membrane potential. Here the script will decide whether 
impalement was successful, and if the oocyte is expressing the correct channels, or it 
was unsuccessful and move on to the next well. If impalement was successful, the script 
then checks if the voltage clamp was successful, and whether leak currents associated 
are within an acceptable range. If this is also successful, Roboocyte2 will then run the 
protocol specific portion of each script. An example of a portion of code can be seen 
below (Fig. 11). 
Figure 11: Sample of Roboocyte2 Scripting. 
A sample of the impalement script in Roboocyte2. The script begins with the logging 
of impalement has begun, before impaling the oocyte. The script determines whether 
the impalement was successful by examining the minimum resting membrane 
potential of the oocyte. If the parameters were not met, the system will move on to the 
next well and repeat. 
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2.4 Shear Stress 
Shear stress was modulated in the system by altering the flow speed of the peristaltic 
pump. To do so, the perfusion head was physically modified, and a calibration curve 
between shear stress applied and peristaltic pump speed was done. 
2.4.1 Shear Force Perfusion Head 
To assess the effects of shear force, the flow applied to each oocyte needed to be 
laminar. Therefore, modifications were made to the proprietary measuring head to 
direct a laminar flow towards the oocyte (Fig. 12). Premium Thin Wall Borosilicate glass 
capillary (Warner Instruments, Cat. No. 64-0784) with an outer diameter of 1.5 mm was 
bent, and then attached to the perfusion tube of the measuring head. The original 
custom perfusion head was supplied by a previous PhD student, Daniel Barth from the 
Department of Physiology (University of Otago) who had confirmed the flows to be 
laminar. Subsequent heads were hand made to mimic the original as close as possible. 
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Glass capillaries of the measuring electrodes were replaced after each experiment. The 
glass capillaries were pulled from Premium Thin Wall Borosilicate glass capillary 
(Warner Instruments, Cat. No. 64-0784) with an outer diameter of 1.5 mm using a 
flaming/brown type micropipette puller (P-87, Sutter Instruments, Novato, USA). The 
tips of the electrode heads needed to be 350 – 450 microns apart when in the perfusion 
head holder to keep the oocyte in place.  
Figure 12: A comparison of the factory perfusion head and the custom perfusion 
head. 
The proprietary perfusion head with a custom glass perfusion tube attached (right) to 
direct laminar shear stress to the oocyte during recording. The original perfusion head 
(left) would not have directed flow directly towards the oocyte. 
 
 
2.4.2 Shear Force Calibration  
To quantify the amount of shear stress applied to each oocyte, we first measured the 
flow rate of the perfusion at a range pump speeds (100-1500 au) of the peristaltic pump. 
We did this by measuring the mass of water collected after 5-minute perfusions at each 
pump speed and divided by 5 to get the mass perfused in 1 minute. Subsequently 
Custom Perfusion Head Original Perfusion Head 
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using the mass, and the known density of water, the volume of water collected can be 





Equation 1: Calculation of volume 
V: volume (cm3) 
m: mass (g) 
ρ: density of water (g/cm3) 
 






Equation 2: Calculation of flow rate 
Q: flow rate (cm3/s) 
V: volume (cm3) 
t: time (s) 
 






Equation 3: Calculation of flow velocity 
ω: flow velocity (cm/s) 
Q: flow rate (cm3/s) 
A: cross-sectional area of perfusion tube (cm3) 
 
The Reynolds numbers (Re) were then calculated to confirm laminar flow of perfusion 







Equation 4: Calculation of Reynolds number 
Re: Reynolds number 
Θ: density of water [20 °C] (g/cm3) 
ω: flow velocity (cm/s) 
D: diameter of perfusion tube (cm) 
λ: kinematic viscosity of water [20 °C] (g/cm.s) 
 
Where θ is the density of water (1 g/cm3 at 20 °C), ω the flow velocity, D the diameter 
of the perfusion capillary, and λ being the kinematic viscosity of water (0.01 g/cm.s). A 
resulting Reynolds number below 1000 indicates laminar flow. 
Following this, the effective drag force was calculated while taking into consideration 





Equation 5: Calculation of effective shear force 
Fdrag: effective drag force (dyn) 
Θ: density of water [20 °C] (g/cm3) 
A: Cross sectional area of oocyte (cm2) 
ω: flow velocity (cm/s) 
Cd: drag coefficient 
 
Where Fdrag is the effective drag force, θ is the density of water, A the cross-sectional 
area of an oocyte, ω the flow velocity, and Cd being the drag coefficient which has a 
value of 1 for Re values in the range of 14 to 80. 








Equation 6: Calculation of effective shear force 
Fshear: shear force (dyn/cm2) 
Fdrag: effective drag force (dyn) 
A: Cross sectional area of oocyte (cm2) 
 
The resulting shear forces used in this experiment ranged from 0.02 to 0.236 dyn/cm2 , 
and corresponds to flow rates as indicated by Figure 13 below: 
Figure 13: Calibration of Laminar Shear Stress to Perfusion Rate.  
The amount of shear stress applied to the oocyte was calibrated to the perfusion rate 
of the peristaltic pump, ranging from 0.88 to 1.39 cm3/min. This range produced a 
laminar shear stress ranging from 0 to 0.236 dyn/cm2. This represented a range of 







2.4.3 Perfusion Protocol 
The perfusion protocol itself to determine the effects of shear force was finalised into 
the outline below: 
1. Amiloride Perfusion (30 s) 
2. Washout (30 s) 
3. Stabilisation (90 s) 
4. Step wise ORi Perfusion 
(1) 0.002 dyn/cm2, 30 s 
(2) 0.009 dyn/cm2, 30 s 
(3) 0.021 dyn/cm2, 8-30 s 
(4) 0.036 dyn/cm2, 8-30 s 
(5) 0.058 dyn/cm2, 8-30 s 
(6) 0.083 dyn/cm2, 8-30 s 
(7) 0.113 dyn/cm2, 8-30 s 
(8) 0.149 dyn/cm2, 8-30 s 
(9) 0.190 dyn/cm2, 8-30 s 
(10) 0.236 dyn/cm2, 8-30 s 
5. Amiloride Perfusion (45 s) 
Firstly, 100 μM amiloride containing ORi was applied to each well (30 s) to fully inhibit 
ENaC present to reduce the noise of the trace. Following this, amiloride was washed 
out with ORi (30 s) and perfusion was stopped to allow stabilisation of the oocyte (90 
s). Then perfusion of ORi began again at a low shear stress of 0.002 dyn/cm2 before 
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being increased in a 10-step wise process at set time intervals up to 0.236 dyn/cm2 as 
shown in the outline above. This was done to determine whether a dose response 
occurs with ENaC. The time interval at step 3 and above varied between 8-30 s to 
account for the reduction in current seen in αβγ-ENaC. Finally, 100 μM amiloride 




2.5 Carbon Monoxide 
Carbon monoxide was administered to the oocyte in the form of an organic carbon 
monoxide releasing molecule, oCOM-21b. This is an experimental drug that was 
supplied by AP Ivan Sammut from the Department of Pharmacology and Toxicology 
(University of Otago).  
2.5.1 Carbon Monoxide Perfusion system 
oCOM-21b is stable in pH 6 solution and does not release Carbon Monoxide. ORi 
solution has a pH of 7.4 and addition of oCOM-21b to ORi results in carbon monoxide 
release from the molecule in a 1:1 ratio (concentration of oCOM-21b = concentration 
of Carbon monoxide release). Because of this, alterations to the perfusion system was 
necessary to minimise time between release and the perfusion well (Fig. 14). 
Figure 14: Schematic of carbon monoxide perfusion. 
A 3-way valve was attached to the perfusion line of the peristaltic pump. This allows 
the attachment of a syringe containing 1 mM oCOM-21b (pH 6) to be perfused into 
the line. A Baby Bee Syringe Drive (Bioanalytical systems, Indiana, USA) powers the 
oCOM-21b perfusion, and its speed is controlled by a Bee Hive Controller (Bioanalytical 
systems, Indiana, USA). Depending on the speed of the Baby Bee, different 














Using a three-way valve, a syringe containing 1 mM oCOM-21b is connected to the 
perfusion system. The syringe was powered by a Baby Bee Syringe Drive (Bioanalytical 
systems, Indiana, USA) and controlled by a Bee Hive Controller (Bioanalytical systems, 
Indiana, USA). The peristaltic pump was set to 1 mL/min and by adjusting the speed of 
the syringe drive, different concentrations of oCOM-21b can be added to the perfusion 
stream. Concentrations of 0.1, 1, and 10 µM oCOM-21b was used in the perfusion by 
setting the speed of the syringe drive to 0.1, 1, and 10 µL/min. 
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2.6 Statistical Analysis 
Data is expressed as the mean ± standard error of the mean (SEM). The number of 
experiments as n, while N indicates the number of animals from which the oocytes were 
harvested from. Electrophysiological data was analysed using GraphPad Prism 7. And 
statistical comparisons were made using one-way ANOVA analysis with multiple 
comparisons (column analysis), two-way ANOVA analysis with multiple comparisons 
(grouped analysis), and unpaired t test (comparing independent values). Tests for 
multiple comparisons includes Dunnett’s multiple comparisons test, Sidak’s multiple 
comparisons test and Tukey’s multiple comparisons test. A p-value less than 0.05 was 










3.1 The Effect of Shear stress on Human Epithelial Sodium 
Channels. 
Here we assessed the effects of shear stress on human αβγ-ENaC and δβγ-ENaC. Shear 
stress was applied in a step wise manner to each oocyte from 0.002 dyn/cm2 up to 
0.236 dyn/cm2 by altering the perfusion speed of oocyte ringer’s solution (Ori). 100 µM 
amiloride (Ami.) perfused at the end of each recording to determine the ENaC-
mediated current. The current under amiloride perfusion was subtracted from each 
recording to determine the amiloride sensitive current, which is the current that is due 
to ENaC. Then percentage activation of ENaC at each shear stress applied was 
calculated, with 0.24 dyn/cm2 set as 100% activation because a plateau is seen here. 
Then currents at each shear stress perfused is calculated as a proportion of that 100%. 
From this, we then calculated the half-maximal effective shear stress for both αβγ-ENaC 
and δβγ-ENaC and compared these values between the two types of ENaCs. 
3.1.1 Shear Stress activates αβγ-ENaC 
Our results indicate that shear stress was able to activate αβγ-ENaC from 17.7 ± 1.1 % 
at 0.002 dyn/cm2 up to 100 % at 0.24 dyn/cm2 in a stepwise manner (n = 5; N = 1) (Fig. 
15). And upon application of amiloride, the amiloride sensitive current was significantly 
reduced. This suggests a dose-dependent response of αβγ-ENaC to laminar shear 
stress. It is important to note that at 0.021 dyn/cm2 and higher, the transmembrane 




Figure 15: Shear Stress activates αβγ-ENaC. 
A: Visual representative current trace of αβγ-ENaC expressing oocyte. The application 
of laminar shear stress (LSS) from 0.002 to 0.0236 dyn/cm2 (blue bar) induces a stepwise 
increase in membrane current. The application of 100 µM amiloride (Ami., yellow bar) 
induces a strong decrease in membrane current and is used to determine the amiloride 
sensitive current. B:   Non-Linear regression of percentage activation of αβγ-ENaC with 
0.236 dyn/cm2 set as 100 % activation. Percentage activation increased in a step wise 













3.1.2 Shear stress activates δβγ-ENaC  
Application of increasing amounts of shear stress showed increased in amiloride 
sensitive current (Fig. 16). This current was inhibited upon application of 100 μM 
amiloride. The results indicate that shear stress was able to activate δβγ-ENaC from 
12.2 ± 2.5 % at 0.002 dyn/cm2 up to 100 % at 0.236 dyn/cm2 in a stepwise manner (n 
= 5, N = 1). Suggesting, δβγ-ENaC responds to shear stress in a dose dependent 
manner. 
Figure 16: Human δβγ-ENaC is activated by Shear Stress. 
A: Visual representative current trace of δβγ-ENaC expressing oocyte. The application 
of shear stress from 0.002 to 0.0236 dyn/cm2 (blue bar) induces a stepwise increase in 
membrane current. The application of 100 µM amiloride (Ami., yellow bar) induces a 
strong decrease in membrane current and is used to determine the amiloride sensitive 
current. Blue arrows indicate time points where shear stress was increased B:   Non-
Linear regression of percentage activation of δβγ-ENaC with 0.236 dyn/cm2 set as 100 
% activation. Percentage activation increased in a step wise manner as shear stress was 
increased in a step wise manner from 0.002 dyn/cm2 up to 0.236 dyn/cm2. 
 
3.1.3 δβγ-ENaC is more sensitive to shear stress than αβγ-ENaC 
From Figures 15B and 16B, the half-maximal effective shear stress for both αβγ-ENaC 






0.007 dyn/cm2 when compared to αβγ-ENaC, which had an EC50 of 0.029± 0.003 
dyn/cm2 (n = 5, N = 1, ***: p = 0.001). This suggests αβγ-ENaC is more sensitive to 
shear stress than δβγ-ENaC. Meaning, for the same amount of shear stress, αβγ-ENaC 
would provide a higher transmembrane current when compared to δβγ-ENaC. 
Figure 17:  Comparison of half-maximal effective shear stress (EC50) between αβγ-
ENaC and δβγ-ENaC. 
The EC50 of αβγ-ENaC and δβγ-ENaC was compared. δβγ-ENaC (n=5) had a significantly 
higher EC50 when compared to αβγ-ENaC (n=5). Unpaired t-test; ***: p < 0.001. 
 
 
3.1.4 Shear stress effect in Xenopus oocytes due to ENaC activation. 
It can be confirmed that the effects observed via shear stress application was due to 
ENaC activation. This can be seen in the water injected control oocytes, where no ENaC 
was expressed (Fig. 18). Application of shear stress in water injected oocytes resulted 





Figure 18: Control experiment for shear stress application. 
Representative current trace of shear stress application on water-injected oocytes. No 






3.2 The effect of carbon monoxide on human epithelial 
sodium channels 
oCOM-21b, an organic carbon monoxide releasing molecule was used to assess the 
effect of carbon monoxide on human αβγ-ENaC and δβγ-ENaC. oCOM-21b was 
perfused at concentrations of 0.1, 1.0, and 10 µM to determine its effect on ENaC 
expressed on Xenopus oocytes. The flow was constant throughout the procedure to 
minimize shear stress effects. A time control was also performed where only Ori, 
without oCOM-21b was perfused over the same length of perfusion time to control for 
run-down currents. Then the time course of the effect at 2 minutes intervals over a 6-
minute perfusion of each concentration was plotted in αβγ-ENaC and δβγ-ENaC. 
However, due to the complexity of the carbon monoxide response as no significant 
result was observed, the data is further analyzed in other ways. The ratio of amiloride 
sensitive current at 6 minutes (t6) over the transmembrane current at 0 minutes (t0) 
oCOM-21b perfusion were calculated at each concentration to get a measure of 
proportionate change in amiloride sensitive current. A t6/t0 ratio below 1 would indicate 
a decrease in amiloride sensitive current over the course of the perfusion, whereas a 
ratio over 1 indicates an increase in amiloride sensitive current, and a ratio of 1 indicates 
no change in amiloride sensitive current. 
Furthermore, a linear regression was done for the 6-minute perfusions to determine 
the slope of the traces. This tells us the rate of change in amiloride sensitive current. 
These were then compared against the time control to determine if there was a 
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difference in rate of change between the concentrations of oCOM-21b as well as 
between αβγ-ENaC and δβγ-ENaC. 
3.2.1 Carbon Monoxide effect on αβγ-ENaC 
Oocyte was perfused initially with Ori to washout the initial amiloride perfused, 
followed by oCOM-21b at the same perfusion rate to minimize effect of shear stress. 
Amiloride (100 µM) was perfused at the end of each recording to determine the ENaC-
mediated current. A time control was done where no oCOM-21b was perfused over 
the same length of time to compare for effects of run-down currents in the oocyte. All 
treatments showed an increase in current during the wash off of amiloride, and the 
current gradually decreased over the course of the oCOM-21b perfusion. And a sharp 






Figure 19: Representative current traces of αβγ-ENaC expressing oocytes. 
A, B, C) Representative current trace of αβγ-ENaC expressing oocytes being perfused 
with oCOM-21b at 0.1, 1.0, and 10 µM concentrations respectively. 100 µM amiloride 
(Ami.) perfusion at the end resulted in a strong decrease in current and is used to 
determine the amiloride sensitive current. D) Representative current trace of αβγ-ENaC 
expressing oocytes being perfused with Ori as a time control (TC) for the experiment. 
 
Quantitively, statistical differences were found at t0 between the time control (-5.4 ± 
1.6 µA, n = 4) and 0.1 (-1.1 ± 0.5 µA, n = 4, **: p < 0.01), 1.0 (-2.4 ± 0.6 µA, n = 5, *: p 
< 0.05), and 10 (-8.6 ± 0.3 µA, n = 3, *: p < 0.05) µM oCOM-21b (Fig. 20). Because all 
oocytes have undergone the same treatment by t0, they should theoretically be very 
similar to each other with similar currents. But because they were all statistically 
different from the time control, it is likely there is high variability between each oocyte. 
Ami. oCOM-21b 0.1 µM ORi 
AmioCOM-21b 10 µM   ORi 
  oCOM-21b 1.0 µM   ORi Ami. 































At t2, a significant difference was found between the time control (-4.8 ± 1.5 µA, n = 4) 
and 0.1 µM oCOM-21b (-1.48 ± 0.35 µA, n = 4, *: p < 0.05). No other significant 
differences were found between the time control and oCOM-21b treatments over the 
6 minute perfusion period. Statistical differences found at t0 suggests large variability 
in αβγ-ENaC expressing oocytes as treatment until then had been identical between all 
groups. 
 
Figure 20: Effect of carbon monoxide on αβγ-ENaC expressing oocytes. 
At t0, all concentrations of oCOM-21b perfusion were significantly different when 
compared to the time control (TC). At t2, only 0.1 µM oCOM-21b perfusion was 
significantly lower when compared to the time control. No other statistically significant 
differences were found between oCOM-21b perfusion and the time control at any 
concentration or time point. 2way ANOVA, Dunnett’s multiple comparisons test; A: at 
t0 between TC and 0.1 µM, p < 0.001; B: at t0 between TC and 1.0 µM, p < 0.05; C: at 
t0 between TC and 10 µM, p < 0.05; D: at t2 between TC and 0.1 µM, p < 0.05. 
 
 
Examining the t6/t0 ratio of each concentration (Fig. 21), no significant differences were 
found between the time control (0.5 ± 0.2, n = 4) and 0.1 (2.1 ± 1.0, n = 4), 1.0 (1.0 ± 
0.2, n = 5), and 10 (0.3 ± 0.1, n = 3) µM oCOM-21b perfusions (p = 0.14). But a biphasic 
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trend could be seen as at a low concentration of oCOM-21b (0.1 μM), the mean t6/t0 
ratio was above one suggesting a stimulatory response. But at a higher concentraion, 
the ratio was below 1, suggesting an inhibitory response. This suggests a possible 
concentration dependent effect of oCOM-21b. 
 
Figure 21: t6/t0 ratios in αβγ-ENaC expressing oocytes. 
No statistical significances were found between the time control t0/t6 ratio and any of 




Examining the slope of each treatment (Fig. 22), significant differences are found 
between the time control (0.41 ± 0.03 µA/min, n = 4) and 0.1 (-0.05 ± 0.04 µA/min, n 
= 4, p = 0.002), 1.0 (0.07 ± 0.06 µA/min, n = 5, p = 0.010), 10 (1.07 ± 0.13 µA/min, n = 
3, p = 0.001) µM. Furthermore, the slope at 10 µM oCOM-21b perfusion was 
significantly greater compared to both 1.0 µM (p < 0.0001) and 0.1 µM (p< 0.0001) 
oCOM-21b perfusion. Suggesting, at 10 µM oCOM-21b perfusion, the rate of decrease 
in current is significantly increased compared to the lower perfusion concentrations. 
This further supports the idea of the biphasic trend noted earlier. It is important to note 
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here that a positive slope is a reduction in current as the amiloride sensitive currents 
are negative values. 
 
Figure 22: Slopes of αβγ-ENaC expressing oocytes. 
Slopes of each treatment was obtained using linear regression, and slopes of all oCOM-
21b perfusions were significantly different when compared to the time control. 10 µM 
oCOM-21b perfusion had a significantly steeper slope when compared to 1.0 and 0.1 
µM oCOm-21b perfusions. Ordinary one-way ANOVA, Tukey’s multiple comparisons 
test; A: between TC and 0.1 µM, p < 0.001; B: between TC and 1.0 µM, p < 0.001; C: 
between TC and 10 µM, p < 0.0001; ****: p < 0.00001. 
 
 
In summary, these results suggest carbon monoxide released by oCOM-21b causes 
some effects in αβγ-ENaC expressed on Xenopus oocytes involving a biphasic response. 
But no statistically significant evidence for the effect of carbon monoxide on αβγ-ENaC 
was found.  
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3.2.2 Effect of Carbon Monoxide on δβγ-ENaC 
The exact same protocol done on αβγ-ENaC expressing oocytes was repeated on δβγ-
ENaC expressing oocytes. And again, visually, the recordings for each treatment were 
similar with an increase in current seen during the wash off of amiloride. The current 
then decreased gradually over the course of the perfusion time and was significantly 
reduced upon amiloride administration. A large discrepancy in the scale bar is noted 
and suggests a high variation in the number of ENaC expressed on the surface between 
each oocyte (Fig. 23). 
Figure 23: Representative current traces of δβγ-ENaC expressing oocytes. 
A, B, C) Representative current trace of δβγ-ENaC expressing oocytes being perfused 
with oCOM-21b at 0.1, 1.0, and 10 µM concentrations respectively. 100 µM amiloride 
(Ami.) perfusion at the end resulted in a strong decrease in current and is used to 
determine the amiloride sensitive current. D) Representative current trace of δβγ-ENaC 
expressing oocytes being perfused with Ori as a time control (TC) for the experiment.  























































Quantitively, no statistical differences were found between the time control and any 
concentrations of oCOM-21b perfused at any time point in δβγ-ENaC expressing 
Xenopus oocytes (Fig. 24). This suggests that there is oCOM-21b likely has no effect on 
δβγ-ENaC. 
Figure 24: Effect of carbon monoxide on δβγ-ENaC expressing oocytes. 
No significant differences were found between the time control and any oCOM-21b 
concentration at any time point. 2way ANOVA, Dunnett’s multiple comparisons test. 
 
 
Furthermore, examining the t6/t0 ratios (Fig. 25), no statistical differences were found 
between the time control and all concentrations of oCOM-21b perfused at any time 
point in δβγ-ENaC expressing Xenopus oocytes. This further suggests that carbon 
monoxide may have no effect on δβγ-ENaC. 
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Figure 25: t6/t0 response to carbon monoxide in δβγ-ENaC. 
No statistical significances were found between the time control t0/t6 ratio and any of 
the oCOM-21b perfusion concentrations. Ordinary one-way ANOVA, Dunnett’s 
multiple comparisons test. 
 
 
Examining the slope of each recording (Fig. 26), only 10 µM (0.75 ± 0.06 µM/min, n = 
5) oCOM-21b treatment was statistically higher when compared to the time control 
(0.10 ± 0.12 µM/min, n = 5) (p < 0.004). No statistical differences were found between 
the time control and 0.1 μM (0.13 ± 0.03, n = 4, p = 0.99), as well as 1.0 μM (0.42 ± 0.12, 
n = 3, p = 0.14). A trend can be observed where a higher concentration of oCOM-21b 
results in a greater slope. This suggests at higher concentrations of oCOM-21b, a 
greater rate of decrease in amiloride sensitive current may be observed in δβγ-ENaC. 
Again, it is important to note that a slope above 0 is an inhibitory response as the 










Figure 26: Slopes of δβγ-ENaC expressing oocytes. 
Slopes of each treatment was obtained using linear regression, no statistical 
significance were found between any group. Ordinary one-way ANOVA, Tukey’s 
multiple comparisons test. 
 
 
These results suggest δβγ-ENaC is not affected by carbon monoxide released by 
oCOM-21b at any concentration. However, this is likely due to the limited number of 
experiments performed as some trends are still visible such as in Figure 26 where there 
is a general increase in slope as the concentration of oCOM-21b was increased. 
3.2.3 The effect of carbon monoxide compared between αβγ-ENaC and 
δβγ-ENaC. 
The t6/t0 ratios (Fig. 27) were compared between αβγ-ENaC expressing oocytes and 
δβγ-ENaC expressing oocytes. We found that there were no significant differences 
between the two types of ENaCs at any concentration of oCOM-21b. This suggests that 
the response is similar between the two ENaCs but it must be noted that the biphasic 




Figure 27: Comparison of t6/t0 ratios between αβγ-ENaC and δβγ-ENaC. 
No statistical significance was found in any treatment between αβγ-ENaC and δβγ-
ENaC. 2way ANOVA, Sidak’s multiple comparisons test 
 
 
However, when comparing the slopes of each treatment between αβγ-ENaC expressing 
oocytes and δβγ-ENaC expressing oocytes (Fig. 28), we found that the time control of 
αβγ-ENaC (0.41 ± 0.03 μA/min, n = 4) had a significantly higher slope when compared 
to δβγ-ENaC (0.10 ± 0.12 μA/min, n = 5, p = 0.036). And at 1.0 µM oCOM-21b perfusion, 
δβγ-ENaC (0.42 ± 0.12 µA/min, n = 3) had a significantly higher slope when compared 
to αβγ-ENaC (0.07 ± 0.06 µA/min, n = 5, p = 0.026)). This suggests variation in response 




Figure 28: Comparison of slopes between αβγ-ENaC and δβγ-ENaC. 
The time control (TC) of αβγ-ENaC had a significantly steeper slope when compared to 
δβγ-ENaC. And at 1.0 µM oCOM-21b perfusion, δβγ-ENaC is significantly steeper 











Hypertension, where blood pressure is increased, results in increased shear stress. We 
aimed to determine how this increase in shear stress may affect αβγ-ENaC and δβγ-
ENaC mediated sodium transport using TEVC. We hypothesized αβγ-ENaC and δβγ-
ENaC both respond to shear stress in a dose dependent manner, and the response is 
likely to be similar between the two types of ENaCs. From our results we were able to 
confirm both forms of ENaC are responsive to shear stress, however, αβγ-ENaC was 
more sensitive to shear stress. Furthermore, increased ENaC activity in the arterial 
endothelium has been shown to inhibit vascular relaxation (Perez et al., 2009), 
potentially exacerbating the effects of hypertension.  
Carbon monoxide have been shown in previous studies to be an inhibitor of αβγ-ENaC 
activity (Althaus et al., 2009), making it a potential treatment in hypertension. But 
unpublished data from the Fronius lab has also found δβγ-ENaC to be present in 
arteries, and how carbon monoxide affects δβγ-ENaC is unknown. Therefore, we aimed 
to examine whether carbon monoxide could potentially inhibit δβγ-ENaC mediated 
sodium transport, and how the effect compares to αβγ-ENaCs. Doing so would pave 
way in placing carbon monoxide as a potential therapeutic in the treatment of 
hypertension. We hypothesized carbon monoxide would inhibit ENaC mediated 
sodium transport in both αβγ-ENaC and δβγ-ENaC. But instead, we found that carbon 
monoxide applied in the form of an organic carbon monoxide releasing molecule, 
oCOM-21b had no effect on ENaC mediated sodium transport in both ENaCs.  
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4.2 ENaC is activated by shear stress 
Shear stress is the stress applied to the walls of an object by the frictional forces of a 
passing flow of fluid. In humans, this phenomenon is found in many regions, but 
importantly in regard to hypertension, shear stress is found in the vasculature. In the 
vasculature, blood flow exerts frictional forces against the surrounding endothelium. 
And under hypertension, where blood flow is increased, the shear stress applied to the 
surrounding endothelium is also increased. 
This is relevant to ENaC as ENaC has been shown to be mechanosensitive and 
responsive to shear stress (Carattino et al., 2004; Althaus et al., 2007; Fronius et al., 2010; 
Abi-Antoun et al., 2011). Shear stress has been shown to upregulate ENaCs open 
probability (Fronius et al., 2010), allowing greater Na+ transport.  And increased ENaC-
mediated sodium transport has been shown to inhibit vascular relaxation via inhibition 
of eNOS (Perez et al., 2009). This is particularly relevant in hypertension where shear 
stress is elevated, which would stimulate ENaC activity, resulting in inhibited vascular 
relaxation, which potentially exacerbates hypertension. Furthermore, unpublished data 
from the Fronius lab has found δβγ-ENaC to be present in human arteries. Therefore, 
understanding how δβγ-ENaC responds to shear stress in comparison to αβγ-ENaC may 
allow further insights into hypertension, and the development of new potential 
therapeutics in its treatment. 
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4.2.1 ENaC responds to shear stress in a dose dependent manner. 
Our results confirm both human αβγ-ENaC and δβγ-ENaC expressed on Xenopus 
oocytes respond to shear stress in a dose-dependent manner. The αβγ-ENaC response 
is consistent with previous literature done using ENaC from multiple species including 
mouse (Satlin et al., 2001; Carattino et al., 2004; Karpushev et al., 2010), Xenopus laevis 
(Althaus et al., 2007), and humans (Fronius et al., 2010). δβγ-ENaCs response to shear 
stress is also consistent with previous literature as shown in a study also done using 
Xenopus laevis oocytes (Abi-Antoun et al., 2011). However, this is the first evidence to 
confirm a dose-dependent response in δβγ-ENaC to shear stress. This is important as 
it suggests depending on the severity of hypertension, δβγ-ENaC may produce a 
different amount of ENaC-mediated sodium transport. But it is unclear whether δβγ-
ENaC may influence eNOS activity. 
The mechanism behind the αβγ-ENaC inhibition of eNOS is currently unclear, other 
than knowing it involves the PI3K/Akt pathway (Perez et al., 2009). However, given 
increased shear stress on αβγ-ENaC and δβγ-ENaC both result in an increased inwards 
sodium current, it is likely that δβγ-ENaC would also produce an inhibitory effect on 
eNOS. Furthermore, since the data also suggests αβγ-ENaC is more sensitive to shear 
stress than δβγ-ENaC, meaning changes in shear stress would produce a greater 
change in response in αβγ-ENaC. It is likely that αβγ-ENaC would affect eNOS to a 
greater degree than δβγ-ENaC under the same amount of shear stress. Therefore, if the 
mechanism of interaction between ENaC and eNOS is dependent on abundance of 
sodium ions, αβγ-ENaC would produce a greater effect. 
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However, it is important to know that much of this is still speculation as the mechanism 
is still not confirmed. And furthermore, one study has indicated that there is no 
interaction between ENaC and eNOS (Ydegaard et al., 2019), but they were also unable 
to consistently identify the presence of ENaC in the arteries and endothelium, which 
confounds their result. Therefore, it is important further confirm the exact mechanism 
in order to have a full grasp of the influence of ENaC on eNOS. 
4.3 Carbon Monoxide and ENaC 
Carbon monoxide administered in the form of carbon monoxide releasing molecules 
(CORMS) is under research as a potential treatment of cardiovascular diseases (Kim & 
Choi, 2018). CORMs have also been shown to influence αβγ-ENaC, but the effect on 
δβγ-ENaC is unknown. However, given it is now known that ENaC-mediated sodium 
transport by both ENaCs is upregulated under increased shear stress such as during 
hypertension. It would be advantageous in confirming whether carbon monoxide is a 
potential inhibitor of ENaC as a potential therapeutic in the treatment of hypertension. 
4.3.1 Carbon monoxide may have a concentration dependent effect on 
αβγ-ENaC 
At the outset, no statistically significant result was seen upon the application of carbon 
monoxide on αβγ-ENaC at all concentrations perfused when compared to the time 
control. This would contradict against current literature as it has been shown carbon 
monoxide influences αβγ-ENaC activity. However, upon further analysis of the data, a 
biphasic trend was noted through the t6/t0 ratios and the rate of change in amiloride 
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sensitive current. This provides potential insights into the conflicting literature on the 
effect of carbon monoxide on αβγ-ENaC now.  
Current literature on the effect of carbon monoxide on αβγ-ENaC suggests both 
inhibitory (Althaus et al., 2009) and stimulatory (Wang et al., 2009) effects. And it is 
currently suggested this is a tissue specific response (Wilkinson & Kemp, 2011) as the 
two studies were done in different type of tissues, one in lung tissue of rabbits, whilst 
the other was done in kidney tissue of mice. However, one other notable difference 
between the two studies besides the type of tissue was the amount of carbon 
monoxide perfused. The study with the inhibitory response perfused the tissue with 
100 μM of carbon monoxide donor (Althaus et al., 2009), whereas the stimulatory 
response was perfused with 100 nM of carbon monoxide donor (Wang et al., 2009). 
This reflects the biphasic trend observed in this project, suggesting ENaC can respond 
differently depending on the concentration of carbon monoxide perfused. 
This is not the first known case of a biphasic response in ENaC. ENaC has also been 
shown to have a biphasic response to other stimulants including gadolinium (Knoepp 
et al., 2017). It was shown that a low concentration of gadolinium resulted in 
upregulation of ENaC activity, whilst high concentration of gadolinium resulted in 
reduced ENaC activity.  The authors here proposed that ENaC had multiple binding 
sites for gadolinium that are concentration specific. Whether this mechanism is similar 
regarding carbon monoxide is unclear, however, Wang et al (2009) did show that the 
inhibitory response was likely due to direct interaction between carbon monoxide and 
histidine residues of αβγ-ENaC. As multiple histidine residues have been shown to be 
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able to modulate αβγ-ENaC mediated sodium transport (Sheng et al., 2004), it does 
suggest the theory of multiple binding sites for carbon monoxide in αβγ-ENaCs is 
plausible. Further research to confirm the binding sites would place a clearer 
understanding in the mechanism behind the biphasic response.  
4.3.2 Carbon monoxide had no effect on δβγ-ENaC 
This project also showed no statistically significant changes in δβγ-ENaC-mediated 
sodium transport upon application of carbon monoxide at any concentration when 
compared to the time control. And furthermore, the biphasic response trend was not 
observed. Instead, it was noted that there was a dose dependent trend when examining 
the rate of change of amiloride sensitive current. It was shown that increased amount 
of carbon monoxide lead to increased rate of decrease in amiloride sensitive current. 
This suggests carbon monoxide likely causes an inhibitory effect on δβγ-ENaC.  
However, as no other studies has examined the effect of carbon monoxide on δβγ-
ENaC, it is difficult to elucidate further information. But, if further studies confirm an 
inhibitory effect on δβγ-ENaC, the inhibitory effect could be advantageous in the 
treatment of hypertension, by reducing eNOS inhibition. 
The reasoning for the lack of significance in the results here likely arises from the 
severely limited number of experiments, with no more than 5 oocytes tested for each 
concentration of carbon monoxide all coming from a single frog. This combined with 
the high variability that was noted at time 0 makes it difficult to determine significance. 
This variability in ENaC injected oocytes is further supported by a previous PhD project 
(Barth D, 2017). Therefore, it would be of significant benefit in repeating the experiment 
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using greater number of oocytes, from different frogs. Doing so would provide a more 
definite answer on the effect of carbon monoxide on δβγ-ENaC. 
4.3.3 Comparing the effect of carbon monoxide between αβγ-ENaC and 
δβγ-ENaC 
Because the α subunit and δ subunit only share 34% gene identity (Hanukoglu & 
Hanukoglu, 2016), it is expected that they function differently when exposed to carbon 
monoxide. This is noted as the biphasic trend was only observed in αβγ-ENaC and not 
in δβγ-ENaC. And furthermore, statistically significant difference in rate of change in 
current between the two ENaCs was found at 0.1 μM carbon monoxide perfusion. This 
suggests the binding site that is responsible for the low carbon monoxide 
concentration induced stimulation of αβγ-ENaC is likely dependent on the α subunit.  
However, with the limited data available from this project, and current literature on the 
effect of carbon monoxide on αβγ-ENaC, it is difficult to further interpret these findings.  
4.4. Methodological considerations and future directions 
Although it was to the best of our abilities to consider factors that may influence the 
outcome of our results, some factors were unable to be controlled for due to the nature 
of the project. 
1. We are unable to confirm that the shear stress applied to the oocyte was laminar 
due to the shape of the well.  This is because the perfusion well is not set up in a linear 
fashion, where there is a net flow from one direction to the other. Instead, the current 
is U shaped, and may result in turbulent flow that exerts an uncertain and unprecise 
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amount of shear stress on ENaC. However, a dose response was still found suggesting 
that the turbulent flow may not have a detrimental effect on the experiment.  
2. The amount of shear stress applied in this project may not reflect that actual 
amount of shear stress experienced by the endothelium in arteries. It has been shown 
shear stress in arteries may rise to ~ 70 dyn/cm2 (Lipowsky, 1995), which is significantly 
higher than the 0.236 dyn/cm2 tested here. However, it is important to note that 
although the lumen of the artery could reach the 70 dyn/cm2 value, the actual surface 
of the endothelium may experience significantly reduced amount of shear stress .This 
is due to the glycocalyx of the endothelium, which may provide a shielding effect on 
the surface itself, significantly reducing the amount of shear stress experienced on the 
surface of the endothelium (van den Berg et al., 2006). Therefore, it would be beneficial 
in devising a method in determining the actual amount of shear stress experienced by 
the endothelial cell surface itself. 
3. Our results cannot be directly translated to the human system. Oocytes and the 
human endothelium are structurally different and may therefore affect the interaction 
between ENaC and Shear Stress. Therefore, further experimentation should be done 
where ENaC is expressed in human cell lines such as HUVEC to confirm the findings in 
this project. 
4. There seems to be a large variability in ENaC expression in oocytes. This is seen 
most clearly in Figure 20 as at time 0, all treatment groups were statistically different 
to the time control even though they had undergone the exact same procedure up to 
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that point. Therefore, it is important in ensuring a larger sample size of oocytes from 
different frogs to account for this variability. 
5. We were unable to confirm the successful release of carbon monoxide from 
oCOM-21b. Although we know that oCOM-21b releases carbon monoxide at pH 7.4, 
the pH of the Ori perfusion solution, we are unable to confirm if CO was able to be 
released during the perfusion time. Furthermore, due to the gaseous nature of carbon 
monoxide, we were unable to confirm the actual concentration of the gas present in 




4.5 Conclusion and future directions 
In conclusion, increased shear stress under hypertension can upregulate ENaC-
mediated sodium transport in both types of ENaCs. This confirms the initial hypothesis 
was correct. However, given the exact mechanism behind the interaction between 
ENaC and eNOS is unclear, we are unable to confirm the effect on hypertension itself. 
Furthermore, carbon monoxide was not found to statistically significantly affect either 
forms of ENaC. But trends were observed, and further experimentation should be done 
to confirm these trends. 
Based on our results, a few different directions for investigation are open. As the current 
literature on the effect of carbon monoxide on ENaC remains elusive, confirming the 
biphasic trend observed in αβγ-ENaC in response to carbon monoxide would aid in the 
development of carbon monoxide in the treatment of hypertension. Additionally, patch 
clamp experimentation would be beneficial here as it would allow detailed and 
nuanced investigation into the underlying mechanism. The role of δβγ-ENaC in 
hypertension is still unclear, therefore, confirming whether δβγ-ENaC may also inhibit 
vascular relaxation through the same eNOS pathway as αβγ-ENaC would provide 
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